http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1942901-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dedd4d7ccb55cf2172c0ac4729772d24 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
filingDate | 2006-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa5c77c29f51ccaa3066991d7936ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13242d38eccfd7e967dd2a0e90499f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d763ad6a141aa58ee8cac9117de4e81a |
publicationDate | 2008-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1942901-A2 |
titleOfInvention | Rifamycin analogs and uses thereof |
abstract | The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3'- hydroxy analogs, 5 '-halo and/or alkoxy analogs, and various 4 '-and/or 6'- substituents that incorporate a cyclic amine moiety. |
priorityDate | 2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1511.